Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,955 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07041281RecruitingPhase 2
Spironolactone to improve postpartum blood pressure after pregnancy hypertension
This study tests whether the medication spironolactone can help manage high blood pressure after delivery in people who had gestational hypertension or preeclampsia. It may help prevent long-term heart problems.
Boston, MassachusettsAges 18 years+ - NCT07041489Recruiting
Supplement and serum for hair growth in women with thinning hair
This trial tests whether a combination of a dietary supplement and a topical serum can help women with thinning hair grow thicker, fuller hair. It's designed for women who have noticed mild to moderate hair thinning and want a non-invasive approach.
Birmingham, AlabamaAges 28–65 - NCT07041801RecruitingPhase 1/Phase 2
Stem cell therapy for lupus patients
This trial tests whether a type of stem cell from umbilical cords can help people with systemic lupus erythematosus (an autoimmune disease). It aims to find a new way to reduce lupus symptoms and improve quality of life.
Shenzhen, GuangdongAges 18–65 - NCT07042126RecruitingPhase 3
Testing 611 for Teen Eczema (moderate to severe)
This trial tests a new injectable medicine (611) for teenagers with moderate to severe eczema that hasn't been helped enough by creams. It aims to see if the drug can safely reduce itching and skin symptoms.
Beijing, Beijing MunicipalityAges 12–17 - NCT07044297RecruitingPhase 3
A study of a new long-acting shot to prevent HIV
This study tests an investigational long-acting shot (MK-8527) to prevent HIV. It is for HIV-negative people who are at higher risk through anal sex without condoms, and who have not used other long-acting HIV prevention before.
Birmingham, AlabamaAges 16 years+ - NCT07046559RecruitingPhase 1
Testing a new drug's safety in healthy volunteers
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
Holbeck, LeedsAges 18–65 - NCT07046611RecruitingPhase 2/Phase 3
Ketamine and Levetiracetam for Seizures in Children
This study tests whether two medicines, ketamine (a sleep medicine) and levetiracetam (a seizure medicine), work better than a standard treatment for stopping long-lasting seizures in children when the first rescue medicine doesn't work.
SohagAges 1–16 - NCT07046806RecruitingPhase 1/Phase 2
Oral deucrictibant for hereditary angioedema attacks
This trial tests an oral medication called deucrictibant to prevent and treat swelling attacks in people with hereditary angioedema. It may help reduce the number and severity of attacks.
Wheaton, MarylandAges 18–75 - NCT07047339RecruitingPhase 2/Phase 3
Probiotic 6600 for colitis patients
This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.
ShanghaiAges 18–75 - NCT07047404RecruitingPhase 2
Testing a new drug for lifelong premature ejaculation
This study tests an experimental drug called BP1.4979 to see if it can help men with lifelong premature ejaculation (PE) last longer during sex. The trial is for men who have had PE since their first sexual experiences and who typically ejaculate within about 1 minute.
NîmesAges 18–50 - NCT07047690RecruitingPhase 2
Nemolizumab for adults with scleroderma
This study tests an investigational drug called nemolizumab for adults with systemic sclerosis (scleroderma). It aims to see if the drug can help reduce skin thickening and other symptoms, especially in people with early or moderate disease.
Ann Arbor, MichiganAges 18 years+ - NCT07048860Recruiting
Pilot study: intense exercise and coaching for older adults with weight and memory concerns
This pilot study tests a program to help older adults who are overweight, sedentary, and have mild memory changes. The goal is to see if intense, supervised physical activity and lifestyle coaching can improve mobility and thinking.
ToulouseAges 65–85 - NCT07050693Recruiting
Can a breast-milk sugar supplement prevent colds and stomach bugs?
This study tests a chewable supplement made from a natural sugar found in breast milk (2'-fucosyllactose) to see if it helps prevent colds and stomach bugs in young children who attend daycare or school. It is for healthy children between 1 and 4 years old.
Bari, BariAges 1–4 - NCT07051629RecruitingPhase 1
Testing a new epilepsy medicine for safety in healthy people and patients
This study tests a new medicine called SIF001 for safety. It first gives the medicine to healthy volunteers, and then to people with epilepsy who have seizures even while on their current medicines. The goal is to find a safe dose.
Tucson, ArizonaAges 18–70 - NCT07052513RecruitingPhase 2
White blood cell treatment for kidney injury after heart surgery
This trial tests a treatment made from your own white blood cells to help your kidneys recover after acute kidney injury that happens within 48 hours of heart surgery.
Barcelona, CataloniaAges 18 years+ - NCT07052799RecruitingPhase 3
Should you pause aspirin before a colonoscopy?
This trial compares stopping aspirin versus continuing it before a colonoscopy in people who take aspirin to prevent heart problems. The goal is to find out which approach is safer and works best.
Hong KongAges 18 years+ - NCT07053423RecruitingPhase 4
Dupilumab for COPD with airway inflammation
This study tests if a drug called dupilumab, given as a shot under the skin, can reduce airway inflammation in people aged 40-85 with moderate-to-severe COPD who also have signs of a specific type of inflammation called Type 2. It may help if you have frequent flare-ups and are already using multiple inhalers.
Birmingham, AlabamaAges 40–85 - NCT07054216Recruiting
Probiotic study for healthy newborns
This study tests whether giving a probiotic to infants can help their health. It involves pregnant people who plan to breastfeed and give birth at a specific hospital.
Hvidovre, Region SjællandAges birth–1 day - NCT07058883Recruiting
Study of Juläine Gel for Facial Acne Scars
This study is testing an investigational gel called Juläine to see if it can safely and effectively improve depressed acne scars on the face. If you have moderate to severe atrophic facial scars and haven't had other facial treatments recently, you may be a good candidate.
GdanskAges 18 years+ - NCT07059546Recruiting
Studying sensitivity to adrenomedullin in chronic post-traumatic headache
This trial tests whether people with long-term headache after a mild head injury have an abnormal reaction to a substance called adrenomedullin, which may play a role in causing headaches. You will receive adrenomedullin and a placebo in separate sessions to see how your headache responds.
Glostrup MunicipalityAges 18–65 - NCT07059767RecruitingPhase 2
Nasal spray for asthma symptoms from colds
This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.
LondonAges 18–65 - NCT07060456RecruitingPhase 3
New drug for type 2 diabetes with insulin
This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07063095RecruitingPhase 3
Testing two antibiotics combined for serious bacterial infections
This study tests whether combining two antibiotics (ceftazidime and fosfomycin) works better than ceftazidime alone for hospitalized adults with serious bacterial infections. If you have a severe infection thought to be caused by Gram-negative bacteria, this trial may offer a new treatment option.
Geneva, Canton of GenevaAges 18 years+ - NCT07063173Recruiting
Tart cherry drink and bar absorption study
This trial looks at how well your body absorbs nutrients from tart cherry extract in a drink and a bar. It might help if you're interested in how food ingredients work in the body.
Natick, MassachusettsAges 17–39
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,955 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.